Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment-Reference-Cited by-同舟云学术

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment

Published:2018-08-30 Issue:12 Volume:20 Page:2860-2868
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Javier Escalada F.¹^ORCID,Halimi Serge²³,Senior Peter A.⁴⁵,Bonnemaire Mireille⁶,Cali Anna M. G.⁶,Melas-Melt Lydie⁷,Karalliedde Janaka⁸^ORCID,Ritzel Robert A.⁹^ORCID

Affiliation:

1. Department of Endocrinology and Nutrition; Clínic University of Navarra; Pamplona Spain

2. Department of Diabetology, Endocrinology and Nutrition; Grenoble University Hospital Center; Grenoble France

3. Department of Diabetology, Endocrinology and Nutrition; University Grenoble Alpes, Medical and Science University; Grenoble France

4. Division of Endocrinology; University of Alberta; Edmonton Canada

5. Diabetic Nephropathy Prevention Clinics, Alberta Health Services; Edmonton Canada

6. Sanofi; Paris France

7. IVIDATA; Levallois-Perret France

8. Cardiovascular Division, Faculty of Life Sciences and Medicine; King's College London; London UK

9. Division of Endocrinology and Diabetes Klinikum Schwabing; Städtisches Klinikum München GmbH; Munich Germany

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13470/fullpdf

Reference21 articles.

1. Diabetic kidney disease: a report from an ADA Consensus Conference;Tuttle;Am J Kidney Dis,2014

2. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States;Saran;Am J Kidney Dis,2016

3. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice;New;Diabet Med,2007

4. Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease);Szczech;PLoS One,2014

5. Aging and chronic kidney disease;Nitta;Kidney Blood Press Res,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel;Diabetes Therapy;2024-03-12

2. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review;Diabetes, Obesity and Metabolism;2024-01-15

3. Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review;Current Diabetes Reviews;2023-11

4. Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100);Clinical Diabetes;2023-03-28

5. Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies;Diabetes Therapy;2022-03-30